INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial

INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial

Abstract Background The effectiveness of erythropoiesis-stimulating agents, which are the main stay of managing anaemia of chronic kidney disease (CKD), is largely dependent on adequate body iron stores. The iron stores are determined by the levels of serum ferritin concentration and transferrin sat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sandawana William Majoni, Jane Nelson, Darren Germaine, Libby Hoppo, Stephanie Long, Shilpa Divakaran, Brandon Turner, Jessica Graham, Sajiv Cherian, Basant Pawar, Geetha Rathnayake, Bianca Heron, Louise Maple-Brown, Robert Batey, Peter Morris, Jane Davies, David ( Kiran) Fernandes, Madhivanan Sundaram, Asanga Abeyaratne, Yun Hui Sheryl Wong, Paul D. Lawton, Sean Taylor, Federica Barzi, Alan Cass, for the INFERR study Group
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Aboriginal and Torres Strait Islander Australians
First Nations Australians
Anaemia
Chronic kidney disease
Maintenance haemodialysis
Ferritin
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/1a24ef81047e499fa808e6646b9d55da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/1a24ef81047e499fa808e6646b9d55da

Ejemplares similares